Cargando…

A universal UHPLC-CAD platform for the quantification of polysaccharide antigens

Several glycoconjugate-based vaccines against bacterial infections have been developed and licensed for human use. Polysaccharide (PS) analysis and characterization is therefore critical to profile the composition of polysaccharide-based vaccines. For PS content quantification, the majority of Ultra...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrado, A., De Martino, M., Bordoni, V., Giannini, S., Rech, F., Cianetti, S., Berti, F., Magagnoli, C., De Ricco, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313704/
https://www.ncbi.nlm.nih.gov/pubmed/37391501
http://dx.doi.org/10.1038/s41598-023-37832-4
_version_ 1785067173292539904
author Corrado, A.
De Martino, M.
Bordoni, V.
Giannini, S.
Rech, F.
Cianetti, S.
Berti, F.
Magagnoli, C.
De Ricco, R.
author_facet Corrado, A.
De Martino, M.
Bordoni, V.
Giannini, S.
Rech, F.
Cianetti, S.
Berti, F.
Magagnoli, C.
De Ricco, R.
author_sort Corrado, A.
collection PubMed
description Several glycoconjugate-based vaccines against bacterial infections have been developed and licensed for human use. Polysaccharide (PS) analysis and characterization is therefore critical to profile the composition of polysaccharide-based vaccines. For PS content quantification, the majority of Ultra High Performance Liquid Chromatography (UHPLC) methods rely on the detection of selective monosaccharides constituting the PS repeating unit, therefore requiring chemical cleavage and tailored development: only a few methods directly quantify the intact PS. The introduction of charged aerosol detector (CAD) technology has improved the response of polysaccharide analytes, offering greater sensitivity than other detector sources (e.g., ELSD). Herein, we report the development of a universal UHPLC-CAD method (UniQS) for the quantification and quality evaluation of polysaccharide antigens (e.g., Streptococcus Pneumoniae, Neisseria meningitidis and Staphylococcus aureus). This work laid the foundation for a universal UHPLC-CAD format that could play an important role in future vaccine research and development helping to reduce time, efforts, and costs.
format Online
Article
Text
id pubmed-10313704
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103137042023-07-02 A universal UHPLC-CAD platform for the quantification of polysaccharide antigens Corrado, A. De Martino, M. Bordoni, V. Giannini, S. Rech, F. Cianetti, S. Berti, F. Magagnoli, C. De Ricco, R. Sci Rep Article Several glycoconjugate-based vaccines against bacterial infections have been developed and licensed for human use. Polysaccharide (PS) analysis and characterization is therefore critical to profile the composition of polysaccharide-based vaccines. For PS content quantification, the majority of Ultra High Performance Liquid Chromatography (UHPLC) methods rely on the detection of selective monosaccharides constituting the PS repeating unit, therefore requiring chemical cleavage and tailored development: only a few methods directly quantify the intact PS. The introduction of charged aerosol detector (CAD) technology has improved the response of polysaccharide analytes, offering greater sensitivity than other detector sources (e.g., ELSD). Herein, we report the development of a universal UHPLC-CAD method (UniQS) for the quantification and quality evaluation of polysaccharide antigens (e.g., Streptococcus Pneumoniae, Neisseria meningitidis and Staphylococcus aureus). This work laid the foundation for a universal UHPLC-CAD format that could play an important role in future vaccine research and development helping to reduce time, efforts, and costs. Nature Publishing Group UK 2023-06-30 /pmc/articles/PMC10313704/ /pubmed/37391501 http://dx.doi.org/10.1038/s41598-023-37832-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Corrado, A.
De Martino, M.
Bordoni, V.
Giannini, S.
Rech, F.
Cianetti, S.
Berti, F.
Magagnoli, C.
De Ricco, R.
A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title_full A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title_fullStr A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title_full_unstemmed A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title_short A universal UHPLC-CAD platform for the quantification of polysaccharide antigens
title_sort universal uhplc-cad platform for the quantification of polysaccharide antigens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313704/
https://www.ncbi.nlm.nih.gov/pubmed/37391501
http://dx.doi.org/10.1038/s41598-023-37832-4
work_keys_str_mv AT corradoa auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT demartinom auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT bordoniv auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT gianninis auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT rechf auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT cianettis auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT bertif auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT magagnolic auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT dericcor auniversaluhplccadplatformforthequantificationofpolysaccharideantigens
AT corradoa universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT demartinom universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT bordoniv universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT gianninis universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT rechf universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT cianettis universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT bertif universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT magagnolic universaluhplccadplatformforthequantificationofpolysaccharideantigens
AT dericcor universaluhplccadplatformforthequantificationofpolysaccharideantigens